The Company is a pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation.
Please bookmark us
No comments:
Post a Comment